| Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia CS Tam, S O'Brien, W Wierda, H Kantarjian, S Wen, KA Do, DA Thomas, ... Blood, The Journal of the American Society of Hematology 112 (4), 975-980, 2008 | 926 | 2008 |
| Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia W Wierda, S O’Brien, S Wen, S Faderl, G Garcia-Manero, D Thomas, ... Journal of clinical oncology 23 (18), 4070-4078, 2005 | 703 | 2005 |
| CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma P Sharma, Y Shen, S Wen, S Yamada, AA Jungbluth, S Gnjatic, ... Proceedings of the National Academy of Sciences 104 (10), 3967-3972, 2007 | 608 | 2007 |
| Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative AM Tsimberidou, NG Iskander, DS Hong, JJ Wheler, GS Falchook, S Fu, ... Clinical cancer research 18 (22), 6373-6383, 2012 | 601 | 2012 |
| Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with … S Kopetz, PM Hoff, JS Morris, RA Wolff, C Eng, KY Glover, R Adinin, ... Journal of clinical oncology 28 (3), 453-459, 2010 | 546 | 2010 |
| Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia A Ferrajoli, BN Lee, EJ Schlette, SM O'Brien, H Gao, S Wen, WG Wierda, ... Blood, The Journal of the American Society of Hematology 111 (11), 5291-5297, 2008 | 529 | 2008 |
| Platinum-based chemotherapy for variant castrate-resistant prostate cancer AM Aparicio, AL Harzstark, PG Corn, S Wen, JC Araujo, SM Tu, ... Clinical cancer research 19 (13), 3621-3630, 2013 | 473 | 2013 |
| Multimodality management of urachal carcinoma: the MD Anderson Cancer Center experience AO Siefker-Radtke, J Gee, YU Shen, S Wen, D Daliani, RE Millikan, ... The Journal of urology 169 (4), 1295-1298, 2003 | 404 | 2003 |
| The analysis of gene expression data: an overview of methods and software G Parmigiani, ES Garrett, RA Irizarry, SL Zeger The analysis of gene expression data: methods and software, 1-45, 2003 | 391 | 2003 |
| Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study LC Pagliaro, DL Williams, D Daliani, MB Williams, W Osai, M Kincaid, ... Journal of Clinical Oncology 28 (24), 3851-3857, 2010 | 380 | 2010 |
| Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation AM Tsimberidou, S O'Brien, I Khouri, FJ Giles, HM Kantarjian, R Champlin, ... Journal of Clinical Oncology 24 (15), 2343-2351, 2006 | 344 | 2006 |
| PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3 A Salameh, AK Lee, M Cardó-Vila, DN Nunes, E Efstathiou, FI Staquicini, ... Proceedings of the National Academy of Sciences 112 (27), 8403-8408, 2015 | 290 | 2015 |
| Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma AM Tsimberidou, S Wen, P McLaughlin, S O'Brien, WG Wierda, S Lerner, ... Journal of clinical oncology 27 (6), 904-910, 2009 | 288 | 2009 |
| Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer E Efstathiou, M Titus, S Wen, A Hoang, M Karlou, R Ashe, SM Tu, ... European urology 67 (1), 53-60, 2015 | 282 | 2015 |
| Myeloid sarcoma is associated with superior event‐free survival and overall survival compared with acute myeloid leukemia AM Tsimberidou, HM Kantarjian, S Wen, MJ Keating, S O'Brien, M Brandt, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 248 | 2008 |
| Detection of MRD may predict the outcome of patients with Philadelphia chromosome–positive ALL treated with tyrosine kinase inhibitors plus chemotherapy F Ravandi, JL Jorgensen, DA Thomas, S O’Brien, R Garris, S Faderl, ... Blood, The Journal of the American Society of Hematology 122 (7), 1214-1221, 2013 | 244 | 2013 |
| Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone E Efstathiou, M Titus, D Tsavachidou, V Tzelepi, S Wen, A Hoang, ... Journal of clinical oncology 30 (6), 637-643, 2012 | 234 | 2012 |
| Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses AM Tsimberidou, S Wen, DS Hong, JJ Wheler, GS Falchook, S Fu, ... Clinical cancer research 20 (18), 4827-4836, 2014 | 228 | 2014 |
| Increased Frequency of ICOS+ CD4 T Cells as a Pharmacodynamic Biomarker for Anti-CTLA-4 Therapy D Ng Tang, Y Shen, J Sun, S Wen, JD Wolchok, J Yuan, JP Allison, ... Cancer immunology research 1 (4), 229-234, 2013 | 222 | 2013 |
| Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia XC Badoux, MJ Keating, S Wen, BN Lee, M Sivina, J Reuben, WG Wierda, ... Blood, The Journal of the American Society of Hematology 118 (13), 3489-3498, 2011 | 221 | 2011 |
Kim-Anh DoMD Anderson Cancer CenterEmail verificata su mdanderson.org
